We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Long-Term Safety Shown for Laser Eye Surgery

By HospiMedica staff writers
Posted on 13 Dec 2006
A new study has found that laser surgery to correct nearsightedness has safe long-term results. More...


Researchers from Miguel Hernandez University (Alicante, Spain) evaluated 200 eyes with nearsightedness (myopia) or with myopia and astigmatism. One hundred eyes were corrected with LASIK ((laser in-situ keratomileusis), while the other 100 were corrected with PRK (photorefractive keratectomy).

The researchers examined the patients, who were on average 29 years old when the surgeries were performed in 1995-1996, and measured each patient's vision, evaluating changes on the cornea. Most of the vision correction remained relatively stable, and the vision of both groups regressed only slightly. The study was presented at the joint annual meeting of the American Academy of Ophthalmology and the Asia Pacific Academy of Ophthalmology, held in November 2006 in Las Vegas (NV, USA).

"Our findings are that both are safe after 10 years,” said lead researcher Jorge Alio, M.D., Ph.D., professor and chairman of ophthalmology at Miguel Hernandez University and medical director of Vissum (Alicante, Spain). "They read the line [on the eye chart] above what they used to read.”

In refractive surgery, a microkeratome is first used to cut a hinged flap of corneal tissue off the outer layer of the eyeball. Lasers are then used to reshape and remove parts of the cornea so that light entering the eye re-focuses on the retina, restoring refraction to normal.



Related Links:
Vissum
Miguel Hernandez University

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.